GB0300914D0 - Vaccines - Google Patents

Vaccines

Info

Publication number
GB0300914D0
GB0300914D0 GB0300914A GB0300914A GB0300914D0 GB 0300914 D0 GB0300914 D0 GB 0300914D0 GB 0300914 A GB0300914 A GB 0300914A GB 0300914 A GB0300914 A GB 0300914A GB 0300914 D0 GB0300914 D0 GB 0300914D0
Authority
GB
United Kingdom
Prior art keywords
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0300914A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
GlaxoSmithKline Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Biologicals SA filed Critical GlaxoSmithKline Biologicals SA
Priority to GB0300914A priority Critical patent/GB0300914D0/en
Publication of GB0300914D0 publication Critical patent/GB0300914D0/en
Priority to MXPA04012443A priority patent/MXPA04012443A/en
Priority to ES03757056T priority patent/ES2285174T3/en
Priority to AU2003246411A priority patent/AU2003246411A1/en
Priority to RU2004135541/13A priority patent/RU2004135541A/en
Priority to AT03757056T priority patent/ATE359295T1/en
Priority to IL16537203A priority patent/IL165372A0/en
Priority to PCT/EP2003/006096 priority patent/WO2003104272A1/en
Priority to SI200330857T priority patent/SI1511768T1/en
Priority to CNB038194872A priority patent/CN100360558C/en
Priority to DE60313163T priority patent/DE60313163T2/en
Priority to PL03374534A priority patent/PL374534A1/en
Priority to PT03757056T priority patent/PT1511768E/en
Priority to KR10-2004-7020138A priority patent/KR20050010040A/en
Priority to NZ537125A priority patent/NZ537125A/en
Priority to JP2004511340A priority patent/JP2006512047A/en
Priority to EP03757056A priority patent/EP1511768B1/en
Priority to CA002487831A priority patent/CA2487831A1/en
Priority to DK03757056T priority patent/DK1511768T3/en
Priority to US10/517,420 priority patent/US20060147477A1/en
Priority to BR0311732-4A priority patent/BR0311732A/en
Priority to PE2003000573A priority patent/PE20040554A1/en
Priority to MYPI20032146A priority patent/MY139557A/en
Priority to ARP030102046A priority patent/AR040178A1/en
Priority to UY27840A priority patent/UY27840A1/en
Priority to TW092115540A priority patent/TW200400970A/en
Priority to IS7547A priority patent/IS7547A/en
Priority to NO20045148A priority patent/NO20045148L/en
Priority to CO04122511A priority patent/CO5631450A2/en
Priority to HK05107152A priority patent/HK1074846A1/en
Ceased legal-status Critical Current

Links

GB0300914A 2002-06-11 2003-01-15 Vaccines Ceased GB0300914D0 (en)

Priority Applications (30)

Application Number Priority Date Filing Date Title
GB0300914A GB0300914D0 (en) 2003-01-15 2003-01-15 Vaccines
BR0311732-4A BR0311732A (en) 2002-06-11 2003-06-06 Fusion partner protein, nucleic acid sequence, expression vector, host, immunogenic composition, process for preparing an immunogenic composition, process for producing a fusion protein, use of a protein or DNA sequence, and, Method To Treat A Cancer Patient
NZ537125A NZ537125A (en) 2002-06-11 2003-06-06 Immunogenic compositions
EP03757056A EP1511768B1 (en) 2002-06-11 2003-06-06 Immunogenic compositions
ES03757056T ES2285174T3 (en) 2002-06-11 2003-06-06 IMMUNOGENIC COMPOSITIONS.
RU2004135541/13A RU2004135541A (en) 2002-06-11 2003-06-06 IMMUNOGENIC COMPOSITIONS
AT03757056T ATE359295T1 (en) 2002-06-11 2003-06-06 IMMUNOGENIC COMPOSITIONS
IL16537203A IL165372A0 (en) 2002-06-11 2003-06-06 Immunodenic compositions
PCT/EP2003/006096 WO2003104272A1 (en) 2002-06-11 2003-06-06 Immunogenic compositions
SI200330857T SI1511768T1 (en) 2002-06-11 2003-06-06 Immunogenic compositions
CNB038194872A CN100360558C (en) 2002-06-11 2003-06-06 Immunogenic compositions
DE60313163T DE60313163T2 (en) 2002-06-11 2003-06-06 IMMUNOGENIC COMPOSITIONS
PL03374534A PL374534A1 (en) 2002-06-11 2003-06-06 Immunogenic compositions
PT03757056T PT1511768E (en) 2002-06-11 2003-06-06 Immunogenic compositions
KR10-2004-7020138A KR20050010040A (en) 2002-06-11 2003-06-06 Immunogenic compositions
MXPA04012443A MXPA04012443A (en) 2002-06-11 2003-06-06 Immunogenic compositions.
JP2004511340A JP2006512047A (en) 2002-06-11 2003-06-06 Immunogenic composition
AU2003246411A AU2003246411A1 (en) 2002-06-11 2003-06-06 Immunogenic compositions
CA002487831A CA2487831A1 (en) 2002-06-11 2003-06-06 Immunogenic compositions
DK03757056T DK1511768T3 (en) 2002-06-11 2003-06-06 Immunogenic Compositions
US10/517,420 US20060147477A1 (en) 2002-06-11 2003-06-06 Immunogenic compositions
TW092115540A TW200400970A (en) 2002-06-11 2003-06-09 Immunogenic compositions
PE2003000573A PE20040554A1 (en) 2002-06-11 2003-06-09 VACCINES INVOLVING FUSION PROTEINS
MYPI20032146A MY139557A (en) 2002-06-11 2003-06-09 A fusion partner protein comprising a choline binding domain and a heterologous promiscuous t helper epitope
ARP030102046A AR040178A1 (en) 2002-06-11 2003-06-09 FUSION COUPLE PROTEIN WITH DOMINION OF UNION TO HILL AND AN AUXILIARY EPITHOPE T PROMISCUO
UY27840A UY27840A1 (en) 2002-06-11 2003-06-09 VACCINES
IS7547A IS7547A (en) 2002-06-11 2004-11-23 Immunogenic combinations
NO20045148A NO20045148L (en) 2002-06-11 2004-11-25 Immunogenic mixtures
CO04122511A CO5631450A2 (en) 2002-06-11 2004-12-06 IMMUNOGENIC COMPOSITIONS
HK05107152A HK1074846A1 (en) 2002-06-11 2005-08-17 Immunogenic compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0300914A GB0300914D0 (en) 2003-01-15 2003-01-15 Vaccines

Publications (1)

Publication Number Publication Date
GB0300914D0 true GB0300914D0 (en) 2003-02-12

Family

ID=9951204

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0300914A Ceased GB0300914D0 (en) 2002-06-11 2003-01-15 Vaccines

Country Status (1)

Country Link
GB (1) GB0300914D0 (en)

Similar Documents

Publication Publication Date Title
GB0226722D0 (en) Vaccine
IL173921A0 (en) Vaccine
GB0329146D0 (en) Vaccine
GB0225788D0 (en) Vaccine
GB0225786D0 (en) Vaccine
GB0212046D0 (en) Vaccines
GB0323840D0 (en) Vaccines
GB0228715D0 (en) Vaccine
GB0305794D0 (en) Vaccine
GB0330079D0 (en) Vaccine
GB0209878D0 (en) Vaccine
GB0321614D0 (en) Vaccines
GB0305793D0 (en) Vaccine
GB0304634D0 (en) Vaccines
AU2003237701A8 (en) Vaccines
GB0206595D0 (en) Vaccine
GB0330007D0 (en) Vaccines
GB0304672D0 (en) Vaccines
GB0300914D0 (en) Vaccines
GB0304635D0 (en) Vaccines
GB0300397D0 (en) Vaccines
GB0313737D0 (en) Improved vaccines
GB0226179D0 (en) Vaccine
GB0223355D0 (en) Vaccine
GB0305028D0 (en) Vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)